ARTICLE | Clinical News
AC-201: Phase II started
January 5, 2015 8:00 AM UTC
TWi began a double-blind, international Phase II trial to compare 100 mg oral AC-201 twice daily for 12 weeks plus febuxostat vs. placebo plus febuxostat in about 140 patients. ...